Clinical Research Directory
Browse clinical research sites, groups, and studies.
Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD)
Sponsor: Luxa Biotechnology, LLC
Summary
The main objective of the study is evaluation of the safety and tolerability of RPESC-RPE-4W as therapy for dry AMD.
Official title: A Phase1/2a, Open-Label Study to Evaluate the Safety and Tolerability of RPE Stem Cell-derived RPE (RPESC-RPE) Transplantation as Therapy for Dry Age-related Macular Degeneration (AMD)
Key Details
Gender
All
Age Range
55 Years - Any
Study Type
INTERVENTIONAL
Enrollment
18
Start Date
2022-04-05
Completion Date
2026-12-01
Last Updated
2025-10-15
Healthy Volunteers
No
Conditions
Interventions
RPESC-RPE-4W
RPESC-RPE-4W
Locations (3)
Retina Vitreous Associates Medical Group
Beverly Hills, California, United States
Spencer Center for Vision Research
Palo Alto, California, United States
University of Michigan Kellogg Eye Center
Ann Arbor, Michigan, United States